COMP <GO>
PHAT vs MPLT // GROSS PROFIT MARGIN
Phathom Pharmaceuticals Inc. (NASDAQ) VS. MapLight Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: PHAT 3
— MPLT 1
■ METRIC PARITY
LAST: $6.22 (-0.95%) • MKT CAP: $503.2M
gross-margins
87.10%
LAST: $7.72 (-3.26%) • MKT CAP: $500.1M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PHAT VS. MPLT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PHAT | MPLT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 87.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -32.40% | -2.60 | MPLT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -0.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | PHAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.5 | 31.5 | +2.02 | PHAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $503.2M | $500.1M | $3.2M | PHAT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PHAT REV | MPLT REV | PHAT GROSS % | MPLT GROSS % | PHAT FCF | MPLT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $175.1M | $0 | 87.1% | — | -$167.0M | -$138.6M |
| FY 2024 | $55.3M | $0 | 85.6% | — | -$266.9M | -$79.6M |
| FY 2023 | $682.0K | — | — | — | -$137.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PHAT // BETA —
MPLT // BETA —